LIZTOX
LIVE

Serial Number

79277955

Owner

Huons Bio Pharma Co., Ltd.

Filing Date

Dec 23, 2019

Add to watchlist:

No watchlists yet
View on USPTO

LIZTOX Trademark

Serial Number: 79277955 • Registration: 6155844

LIZTOX is a trademark filed by Huons Bio Pharma Co., Ltd. on December 23, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Huons Bio Pharma Co., Ltd. (2 trademarks)

7F, A-dong, 17, Changeop-ro,

Entity Type: 03

Huons Global Co., Ltd.

9F A-dong, 17, Changeop-ro,

Entity Type: 03

Trademark Details

Filing Date

December 23, 2019

Registration Date

September 22, 2020

Published for Opposition

July 7, 2020

Goods & Services

Food for babies; lactose for pharmaceutical purposes; nutritional supplements; pharmaceutical agents affecting sensory organs; pharmaceutical preparations for treating diabetes; pharmaceutical agents affecting metabolism; pharmaceutical agents affecting peripheral nervous system; pharmaceutical products for the treatment of viral diseases; pharmaceuticals for the treatment of erectile dysfunction; pharmaceuticals being medicines for alleviating constipation; pharmaceutical products for the treatment of bone diseases; pharmaceutical agents affecting digestive organs; cardiovascular pharmaceutical preparations; pharmaceutical preparations, namely, ophthalmic preparations; pharmaceutical preparations for treating allergies; pharmaceutical products for the treatment of cancer; pharmaceutical agents for epidermis; pharmaceuticals being medicines for the treatment of gastrointestinal diseases; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for treating asthma; pharmaceuticals being medicines for dental purposes; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for the treatment of hormonal disorders; pharmaceutical preparations for respiratory organs; pharmaceuticals being antihistamines; pharmaceutical preparations for the prevention of osteoporosis; pharmaceutical preparations for the treatment of osteoporosis; pharmaceutical preparations for the treatment of diseases of the endocrine system; pharmaceutical preparations for use in urology; pharmaceutical preparations for the treatment of diseases of the genitourinary system; pharmaceutical preparations for the prevention of diseases of the genitourinary system; pharmaceutical preparations for treating obesity; pharmaceuticals being cardiotonics; cardiovascular pharmaceuticals; pharmaceutical preparations, namely, antipyretic preparations; pharmaceutical preparations, namely, analgesic preparations; pharmaceutical preparations, namely, anti-inflammatory preparations; pharmaceuticals being anaesthetics; pharmaceutical products for the treatment of infectious diseases; pharmaceuticals being chemotherapeutics; pharmaceuticals being psychotropics; pharmaceutical products for skin care for animals; pharmaceutical preparations for the treatment of worms in pets; Veterinary preparations, namely, anti-infective products for veterinary use; Veterinary preparations, namely, veterinary vaccines; veterinary preparations for treatment of intestinal bacteria; food supplements; dietary supplements; nutraceuticals for use as dietary supplements; nutraceutical preparations for therapeutic or medical purposes for the treatment of obesity; nutraceutical preparations for therapeutic or medical purposes for the treatment of intestinal disorders; nutraceutical preparations for therapeutic or medical purposes for the treatment of allergies; nutraceutical preparations for therapeutic or medical purposes for the treatment of gastrointestinal diseases; medicated plasters; deodorants, other than for human beings or for animals, namely, air deodorants, deodorants for clothing, deodorants for textiles, household deodorants, and room deodorants; bacterial preparations for medical and veterinary use; medicine cases, portable, filled, with pharmaceutical preparations for the treatment of viral diseases; medicine cases, portable, filled, with pharmaceutical preparations for the treatment of intestinal disorders; medicine cases, portable, filled, with pharmaceutical preparations for the treatment of inflammatory diseases; sanitary pads; adhesives for dentures; diapers for incontinence; babies' diapers; diapers for pets; fly glue; mothproofing paper

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
May 7, 2026 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Sep 22, 2025 REM3
CHANGE OF OWNER RECEIVED FROM IB
Aug 28, 2021 CHLD
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 30, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 8, 2021 FICS
FINAL DISPOSITION PROCESSED
Jan 8, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 22, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Sep 22, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 7, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jul 7, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 17, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 2, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 14, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 14, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 14, 2020 TROA
REFUSAL PROCESSED BY IB
May 1, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 9, 2020 RFCS
REFUSAL PROCESSED BY MPU
Apr 9, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 25, 2020 RFCR
NON-FINAL ACTION WRITTEN
Mar 24, 2020 CNRT
ASSIGNED TO EXAMINER
Mar 19, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 15, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 11, 2020 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Feb 10, 2020 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 6, 2020 REPR